Stayble Therapeutics AB (publ)

DB:4K4 Stock Report

Market Cap: €2.7m

Stayble Therapeutics Balance Sheet Health

Financial Health criteria checks 4/6

Stayble Therapeutics has a total shareholder equity of SEK12.2M and total debt of SEK850.0K, which brings its debt-to-equity ratio to 7%. Its total assets and total liabilities are SEK15.8M and SEK3.6M respectively.

Key information

7.0%

Debt to equity ratio

SEK 850.00k

Debt

Interest coverage ration/a
CashSEK 8.06m
EquitySEK 12.22m
Total liabilitiesSEK 3.56m
Total assetsSEK 15.78m

Recent financial health updates

No updates

Recent updates

Financial Position Analysis

Short Term Liabilities: 4K4's short term assets (SEK10.1M) exceed its short term liabilities (SEK2.7M).

Long Term Liabilities: 4K4's short term assets (SEK10.1M) exceed its long term liabilities (SEK850.0K).


Debt to Equity History and Analysis

Debt Level: 4K4 has more cash than its total debt.

Reducing Debt: 4K4's debt to equity ratio has reduced from 25.7% to 7% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 4K4 has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: 4K4 has less than a year of cash runway if free cash flow continues to reduce at historical rates of 23.7% each year


Discover healthy companies